1. Home
  2. FOXO vs KZIA Comparison

FOXO vs KZIA Comparison

Compare FOXO & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOXO
  • KZIA
  • Stock Information
  • Founded
  • FOXO 2019
  • KZIA 1994
  • Country
  • FOXO United States
  • KZIA Australia
  • Employees
  • FOXO N/A
  • KZIA N/A
  • Industry
  • FOXO Retail: Computer Software & Peripheral Equipment
  • KZIA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FOXO Technology
  • KZIA Health Care
  • Exchange
  • FOXO Nasdaq
  • KZIA Nasdaq
  • Market Cap
  • FOXO 4.9M
  • KZIA 6.0M
  • IPO Year
  • FOXO N/A
  • KZIA 1999
  • Fundamental
  • Price
  • FOXO $0.24
  • KZIA $0.89
  • Analyst Decision
  • FOXO
  • KZIA Strong Buy
  • Analyst Count
  • FOXO 0
  • KZIA 2
  • Target Price
  • FOXO N/A
  • KZIA $11.50
  • AVG Volume (30 Days)
  • FOXO 9.1M
  • KZIA 5.5M
  • Earning Date
  • FOXO 11-19-2024
  • KZIA 03-26-2025
  • Dividend Yield
  • FOXO N/A
  • KZIA N/A
  • EPS Growth
  • FOXO N/A
  • KZIA N/A
  • EPS
  • FOXO N/A
  • KZIA N/A
  • Revenue
  • FOXO $1,341,000.00
  • KZIA $1,655,324.00
  • Revenue This Year
  • FOXO N/A
  • KZIA $806.89
  • Revenue Next Year
  • FOXO N/A
  • KZIA N/A
  • P/E Ratio
  • FOXO N/A
  • KZIA N/A
  • Revenue Growth
  • FOXO 196.03
  • KZIA 248000.00
  • 52 Week Low
  • FOXO $0.13
  • KZIA $0.89
  • 52 Week High
  • FOXO $1.30
  • KZIA $15.80
  • Technical
  • Relative Strength Index (RSI)
  • FOXO 46.29
  • KZIA 28.96
  • Support Level
  • FOXO $0.20
  • KZIA $0.90
  • Resistance Level
  • FOXO $0.23
  • KZIA $1.60
  • Average True Range (ATR)
  • FOXO 0.02
  • KZIA 0.24
  • MACD
  • FOXO 0.00
  • KZIA 0.01
  • Stochastic Oscillator
  • FOXO 52.70
  • KZIA 0.00

About FOXO FOXO Technologies Inc.

FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

Share on Social Networks: